South Korea · Delayed Price · Currency is KRW Aprogen Biologics Statistics
Total Valuation
KRX:003060 has a market cap or net worth of KRW 42.28 billion. The enterprise value is 289.25 billion.
| Market Cap | 42.28B |
| Enterprise Value | 289.25B |
Important Dates
The last earnings date was Wednesday, May 20, 2026.
| Earnings Date | May 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:003060 has 13.17 million shares outstanding. The number of shares has increased by 57.15% in one year.
| Current Share Class | 13.17M |
| Shares Outstanding | 13.17M |
| Shares Change (YoY) | +57.15% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 0.95% |
| Float | 5.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.70 |
| EV / Sales | 3.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.04 |
Financial Position
The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.82.
| Current Ratio | 0.67 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.78 |
| Interest Coverage | -11.49 |
Financial Efficiency
Return on equity (ROE) is -51.29% and return on invested capital (ROIC) is -26.88%.
| Return on Equity (ROE) | -51.29% |
| Return on Assets (ROA) | -13.04% |
| Return on Invested Capital (ROIC) | -26.88% |
| Return on Capital Employed (ROCE) | -34.34% |
| Weighted Average Cost of Capital (WACC) | 3.63% |
| Revenue Per Employee | 187.28M |
| Profits Per Employee | -435.63M |
| Employee Count | 391 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.94 |
Taxes
| Income Tax | -1.08B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.51% in the last 52 weeks. The beta is -0.17, so KRX:003060's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -66.51% |
| 50-Day Moving Average | 4,594.40 |
| 200-Day Moving Average | 7,781.45 |
| Relative Strength Index (RSI) | 40.07 |
| Average Volume (20 Days) | 614,535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003060 had revenue of KRW 73.23 billion and -170.33 billion in losses. Loss per share was -12,931.73.
| Revenue | 73.23B |
| Gross Profit | -27.35B |
| Operating Income | -122.89B |
| Pretax Income | -169.38B |
| Net Income | -170.33B |
| EBITDA | -103.70B |
| EBIT | -122.89B |
| Loss Per Share | -12,931.73 |
Balance Sheet
The company has 51.63 billion in cash and 228.80 billion in debt, with a net cash position of -177.16 billion or -13,450.44 per share.
| Cash & Cash Equivalents | 51.63B |
| Total Debt | 228.80B |
| Net Cash | -177.16B |
| Net Cash Per Share | -13,450.44 |
| Equity (Book Value) | 277.57B |
| Book Value Per Share | 15,773.21 |
| Working Capital | -74.60B |
Cash Flow
In the last 12 months, operating cash flow was -38.23 billion and capital expenditures -9.62 billion, giving a free cash flow of -47.86 billion.
| Operating Cash Flow | -38.23B |
| Capital Expenditures | -9.62B |
| Depreciation & Amortization | 19.18B |
| Net Borrowing | 135.14B |
| Free Cash Flow | -47.86B |
| FCF Per Share | -3,633.40 |
Margins
Gross margin is -37.36%, with operating and profit margins of -167.82% and -232.61%.
| Gross Margin | -37.36% |
| Operating Margin | -167.82% |
| Pretax Margin | -231.31% |
| Profit Margin | -232.61% |
| EBITDA Margin | -141.62% |
| EBIT Margin | -167.82% |
| FCF Margin | n/a |
Dividends & Yields
KRX:003060 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.15% |
| Shareholder Yield | -57.15% |
| Earnings Yield | -402.86% |
| FCF Yield | -113.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 13, 2026. It was a reverse split with a ratio of 0.0666666667.
| Last Split Date | Apr 13, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0666666667 |
Scores
KRX:003060 has an Altman Z-Score of -1.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.44 |
| Piotroski F-Score | 2 |